Breast cancer is the most frequent cancer type in females in the Western world, affecting approximately one in ten women. It is a complex genetic disease, with the vast majority of sporadic cases currently unaccounted for by our understanding of the genes and pathways involved. To further understand the mechanisms of breast cancer formation, mammary tumors arising in Brca1 p53 mutant mice were analyzed. The high level of genomic instability conferred by the loss of Brca1 and p53 offers a unique opportunity to study recurrent genomic changes that have been selected for in the context of mammary epithelium. The most pronounced feature of these tumors was the high-level DNA amplification of the Met proto-oncogene, observed in 75 percent of the cases. The goal of this proposal is to further characterize the role of Met signaling in breast cancer formation, with the following experimental aims: 1. Functional consequences of Met amplification in vitro. Met signaling levels will be decreased in tumor derived cell lines and the functional consequences and downstream signaling pathways involved will be analyzed. 2. Contribution of Met signaling to mammary tumorigenesis in mouse models. A transgenetic mouse approach will be used to test whether increased Met signaling is necessary and/or sufficient for breast tumorigenesis. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA117737-03
Application #
7266997
Study Section
Special Emphasis Panel (ZRG1-F09 (20))
Program Officer
Jakowlew, Sonia B
Project Start
2005-08-01
Project End
2008-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
3
Fiscal Year
2007
Total Cost
$53,992
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Zhang, Jianmin; Ji, Jun-Yuan; Yu, Min et al. (2009) YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 11:1444-50
Zhang, Jianmin; Smolen, Gromoslaw A; Haber, Daniel A (2008) Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res 68:2789-94
Smolen, Gromoslaw A; Schott, Benjamin J; Stewart, Rodney A et al. (2007) A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Genes Dev 21:2131-6
Smolen, Gromoslaw A; Muir, Beth; Mohapatra, Gayatry et al. (2006) Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis. Cancer Res 66:3452-5
Overholtzer, Michael; Zhang, Jianmin; Smolen, Gromoslaw A et al. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103:12405-10
Smolen, Gromoslaw A; Sordella, Raffaella; Muir, Beth et al. (2006) Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci U S A 103:2316-21